Aplastic Anemia
Conditions
Interventions
Kidney deficiency and essence injury, marrow deficiency, and blood stasis syndrome:Wenshen Yangxue Huoluo Decoction
Spleen–Kidney?Qi-deficiency, marrow, and collaterals deficiency syndrome:Bushen Jianpi Huoxue Decoction
Marrow and essence deficiency, the depletion of marrow, and blood occlusion syndrome:Bushen Tianjing Huoxue Decoction
Qi and blood weakness, marrow deficiency, and blood stasis syndrome:Sheng Mai Yang Sui Decoction
Marrow and essence deficiency, and blood-heat syndrome:Bushen Tianjing Liangxue Decoction
Spleen?deficiency?and?dampness, marrow deficiency and phlegm?coagulation syndrome:Wenpi Zaoshi Huatan Decoction
Sponsors
The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine)
Eligibility
Sex/Gender
All
Age
16 Years to 80 Years
Inclusion criteria
Inclusion criteria: At the same time, it has the following 6 items : 1 in line with the diagnostic criteria of medullary labor disease ( aplastic anemia ), with reference to the Chinese guidelines for the diagnosis and treatment of aplastic anemia ( 2022 edition ) ; 2 patients aged from 16 to 80 years old ; 3 after the first diagnosis, no standard regimen was used, or the current treatment regimen had been maintained for more than 3 months ; patients included in the efficacy analysis were treated with drugs for at least 12 weeks ; 5 to comply with the study visit schedule, and understand and comply with all research program requirements ; 6 to understand and voluntarily sign a written informed consent.
Exclusion criteria
Exclusion criteria: 1 Severe heart disease included uncontrolled hypertension or hypotension, or severe valvular or endocardial disease in New York Heart Association ( NYHA ) grade III or IV congestive heart failure, resulting in the risk of thromboembolism in the subjects. 2 Clinically active or uncontrolled persistent inflammatory / autoimmune diseases ( such as rheumatoid arthritis, Crohn 's disease, ulcerative colitis, celiac disease, systemic lupus erythematosus, etc. ).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effective rate at 12 weeks; | — |
Secondary
| Measure | Time frame |
|---|---|
| inflammation and metabolism;lipid metabolism; | — |
Countries
China
Contacts
Public ContactBaodong Ye
The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)
Outcome results
None listed